INTRODUCTION
Angelman syndrome (AS) is a neurodevelopmental disorder characterized by severe mental retardation, susceptibility to seizures, speech impairment, ataxia and unique behavioral features, such as inappropriate laughter and autistic features (1, 2) . Most cases of AS are caused by deletion of maternal copy of the UBE3A gene (present within 15q11 -q13) (1, 3) . The loss-of-function mutations in maternally inherited UBE3A have also been identified in a subset of affected individuals (4 -6) . Interestingly, the UBE3A gene is imprinted in the brain with preferential maternal-specific expression particularly in neurons but not in glia (7, 8) . Recently, copy number variation of the UBE3A gene (duplication) has been shown to be also associated with autism (9) . The UBE3A gene encodes a 100 kDa protein [also known as E6-associated protein (E6AP)] that is functionally characterized as a HECT (homologous to E6AP C-terminus) domain family of E3 ubiquitin ligase involved in targeting proteins for their multi-ubiquitination and subsequent degradation by proteasome (10) (11) (12) . Ube3a also functions as a transcriptional co-activator of steroid hormone receptors (13) . Mice deficient for maternal Ube3a exhibit many features of AS, including learning and memory impairment and motor dysfunction (14, 15) . These mice also exhibit defects in hippocampal long-term potentiation, altered function of hippocampal calcium/calmodulin-dependent protein kinase II and abnormal dendritic spine morphology (14, 16, 17) . Further studies in these mice provided evidence that Ube3a is required for experience-dependent cortical plasticity and maturation of neocortex (18, 19) . A recent study showed that Ube3a regulates synaptic function by ubiquitinating and degrading Arc, which is involved in 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid [AMPA] receptor trafficking (20) . All these findings indicate that ubiquitin ligase function of Ube3a is crucial in regulating synaptic function. This is further supported by the fact that many of the AS-associated loss-of-function mutations of UBE3A result in disruption of ubiquitin ligase activity (21) . However, this does not rule out the involvement of coactivator function of Ube3a in AS pathogenesis, as majority of the AS cases are due to loss of expression of Ube3a in the brain. The Ube3A knockout mice show defects in reproductive function and tissuespecific steroid hormone resistance, which could be attributed to the loss of its coactivator function (13, 22, 23) . But, whether the loss of coactivator function of Ube3a is associated with any defects in brain function leading to AS are not known. In the present investigation, we studied the role of Ube3a in glucocorticoid receptor (GR)-mediated signaling pathway and found that Ube3a not only serves as a transcriptional coactivator of GR, but also promotes its proteasomal degradation. The GR signaling pathway is disrupted in Ube3a-maternal-deficient mice brain that eventually leads to increased susceptibility to stress and anxiety in these AS mice.
RESULTS

Ube3a not only acts as a coactivator of GR but also likely promotes its proteasome-mediated degradation
In order to investigate the GR coactivator function of Ube3a, we transiently transfected plasmids encoding Ube3a along with GR-responsive luciferase reporter into neuro 2a cells, 24 h later cells were either left alone or treated with dexamethasone for 12 h. Cells were then collected and subjected to luciferase activity assay. Figure 1A show that the treatment Figure 1 . Ube3a interacts with GR, recruits with GR-responsive promoter and activates GR-dependent transcription. (A) Neuro 2a cells were transiently transfected with plasmids encoding Ube3a or empty pcDNA3.1 along with GRE-Luc and 24 h later cells were treated with dexamethasone (Dex) for 12 h. Cells were then collected and processed for luciferase activity assay as described in Materials and Methods. Values are mean + SD of two independent experiments and each time there were three replicates.
* P , 0.001 when compared with Dex-treated experiment. (B) Neuro 2a cells were transfected with plasmids encoding Ube3a and GR along with GRE-Luc and 24 h of post-transfection, cells were treated with either dexamethasone alone or along with RU486 (10-fold excess). Cells were then collected and processed for luciferase assay. Values are mean + SD of two independent experiments and each time there was three replicates.
* P , 0.001 in comparison with GR-transfected and Dex-treated group. (C) In the top panel, chromatin preparations from mouse brain were immunoprecipitated with GR and Ube3a antibodies and then amplified with the SGK1 promoter or negative control region (NC) -specific primers. In bottom panel, neuro 2a cells were left untreated or treated with dexamethasone (100 nM for 1 h) and then subjected to chromatin immunoprecipitation by GR and Ube3a antibodies. Primers specific for the SGK1 promoter were used to amplify the genomic DNA associated with Ube3a and GR. In the input lanes, 0.1% DNA was used. (D) Mouse cortical brain lysate was co-immunoprecipitated (IP) with Ube3a and GR antibodies and blots were detected using antibodies against Ube3a and GR. The rabbit-specific IgG was used as a negative control. (E) Neuro 2a cells were transiently transfected with pEGFP-N1 and GR-green-fluorescent protein (GFP) plasmids independently and 24 h later cells were collected and subjected to co-immunoprecipitation using GFP antibody. Blots were sequentially probed with GFP (to detect GR-GFP and GFP) and Ube3a antibodies. (F) Cells were plated onto two-well chamber slides and on the following day cells were left untreated or treated with dexamethasone (100 nM) for 1 h. Cells were then processed for double immunofluorescence staining using Ube3a and GR antibodies. Fluorescein isothiocyanate (FITC)-conjugated secondary antibody was used to detect Ube3a and Rhodamine-conjugated secondary antibody was used to label GR. Nuclei were stained with DAPI. Scale bar; 20 mm.
with dexamethasone lead to a significant increase in GR-dependent transactivation, which increased by 2-fold in the presence of Ube3a. Similar results were obtained when neuro 2a cells were transfected with both GR and Ube3a plasmids in equal amount (Fig. 1B) . Antagonist of GR (RU486) blocked the GR-dependent transcriptional activation induced by Ube3a. We also found the recruitment of Ube3a onto the promoter of SGK1 and FKBP5 (GR-responsive genes) in chromatin immunoprecipitation assay, and this recruitment was induced in the presence of ligand (Fig. 1C and Supplementary Material, Fig. S1 ). GR was used as a positive control. Next, we checked the interaction of Ube3a with GR in the brain lysate (prepared from the cerebral cortex of mice) by co-immunoprecipitation assay and found that both endogenous GR and Ube3a interact with each other (Fig. 1D) . The interaction of Ube3a with GR was further confirmed by transiently transfecting GR-green-fluorescent protein (GFP) plasmids into neuro 2a cells followed by co-immunoprecipitation using GFP antibody. Also, in this case, we detected specific interaction of Ube3a with GR-GFP (Fig. 1E ). Immunofluorescence co-localization studies revealed that in normal neuro 2a cells, GR was predominantly localized in the cytoplasm while Ube3a was present in the nucleus. In the nucleus, Ube3a showed diffuse neucleoplasmic distribution along with strong staining in heterochromatin regions. Treatment of dexamethasone caused translocation of GR to the nucleus, where it partially co-localized with Ube3a in the nucleoplasm (Fig. 1F) . The liganded GR apparently did not co-localize with Ube3a in the heterochromatin regions.
Interestingly, when we tried to detect the concentrationdependent effect of Ube3a on the GR transactivation, we found that Ube3a at higher expression levels decreased the GR-dependent transcriptional activation ( Fig. 2A) . However, C833A mutant of Ube3a (lacking ubiquitin ligase activity) at higher level showed increased transactivation of GR, indicating the role of ubiquitin ligase activity of Ube3a in regulation of GR transactivation. Our studies also revealed that higher level of Ube3a stimulated the degradation of GR in the presence of ligand, and this degradation was proteasome dependent ( Fig. 2B and C) . Ube3a also increased the ubiquitination of liganded GR, which was absent in C833A mutant transfected cells (Fig. 2D ). Partial knockdown of Ube3a followed by dexamethasone treatment in neuro 2a cells resulted in increased levels of GR ( 2-fold) and significantly increased GR-dependent transcriptional activity ( Fig. 2E and F) , indicating that Ube3a might be regulating the steady-state levels of liganded GR.
GR-mediated signaling is disrupted in Ube3a-maternal-deficient mice brain
The GR-mediated signaling mechanism in the brain plays a pivotal role in controlling physiological response to stress by regulating the hypothalamo -pituitary -adrenal (HPA) axis and altered function of this signaling could lead to stress-induced cognitive impairment by modulating hippocampal function (24, 25) . Since Ube3a modulates GR transactivation, we further explored altered GR signaling in the brain of Ube3a-maternal-deficient mice (model mice for AS). First, we studied the level of expression of Ube3a, GR and SGK1 (a GR-dependent gene) in different parts of the brain of control and Ube3a-maternal-deficient mice. As shown in Figure 3 , the SGK1 level in the cerebral cortex, hippocampus and cerebellum was significantly reduced in Ube3a-maternal-deficient mice in comparison with their wild-type littermates. Surprisingly, the GR level was significantly reduced specifically in hippocampus but was unaltered in both the cerebral cortex and cerebellum. Staining for Ube3a confirmed the loss of Ube3a expression in different parts of Ube3a-maternal-deficient mice brain. The Ube3a-paternal-deficient mice of similar age group had normal Ube3a expression in the brain and did not show decrease in the level of GR in their hippocampus or down-regulation of SGK1 in different brain regions (Supplementary Material, , treated with dexamethasone and processed for luciferase reporter assay in the similar manner as described in Figure 1A . Cell lysates were then processed for luciferase assay. Values are mean + SD of two independent experiments and each time there were three replicates.
* P , 0.01 in comparison with control. * * P , 0.01 in comparison with 2 mg of Ube3a-transfected group. (B) Cells were trasfected with Ube3a or its mutant (C833A) and 24 h later cells were left untreated or treated with dexamethasone for 12 h and then subjected to immunoblot analysis using antibodies against GR, HA (to detect over-expressed Ube3a and its C833A mutant) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (C) Cells were transfected with either empty pcDNA or Ube3a plasmids, treated with dexamethasone as shown in (B) in the absence or presence of MG132. (D) Neuro 2a cells were transfected with Ube3a or its mutant (C833A) as in (B) and 24 h of post-transfection, cells were treated with dexamethasone (1 mM) and MG132 (10 mM) for 12 h. Collected cells were then processed for co-immunoprecipitation using GR antibody and blots were probed with GR and ubiquitin antibodies. (E and F) Cells were transfected with siRNA specific for either GAPDH or Ube3a (each 50 pmol/well of six-well tissue cultured plate), treated with dexamethasone in the same way as above and then subjected to either luciferase assay (E) or immunoblot analysis (F) using Ube3a, GR and GAPDH antibodies. In (E), values are mean + SD of two independent experiments and each time there were three replicates.
* P , 0.001 in comparison with control. Fig. S2 ). Immunoblot analysis further confirmed significant down-regulation of SGK1 and two other GR-dependent targets [brain-derived neurotrophic factor (BDNF) and FKBP5] in different parts of the brain and of GR specifically in hippocampus of Ube3a-maternal-deficient mice (Fig. 4 ).
Ube3a-maternal-deficient mice are under chronic stress and exhibit increased anxiety-like behavior
The disrupted GR signaling in Ube3a-maternal-deficient mice prompted us to investigate the serum corticosterone levels in these mice along with age-matched wild-type controls. Figure 5A shows that morning basal serum corticosterone level was significantly higher in 4-month-old Ube3a-maternal-deficient mice with respect to age-matched wild-type control and Ube3a-paternal-deficient mice, suggesting that these mutant mice might be under chronic stress. High corticosterone level for prolonged period or chronic stress is well known not only to impair cognitive function but also to induce anxiety-like behavior (24) (25) (26) (27) (28) . Since cognitive dysfunction has been already investigated in these mice, we aimed to study anxiety-like behavior. We used three different experimental paradigms to study the anxiety-like behavior. The novel object recognition task was used to measure visual recognition memory (a model of declarative memory that depends on the function of hippocampus) as well as the anxiety state in these mice along with the wild-type controls. This task is based on the rodent's usual tendency to explore novel objects and avoidance of novel object is thought to correlate with the anxiety level (29, 30) . Additionally, locomotor activity is not critical for this task. In the novel object exploration test, a significant difference was observed in the response of wild-type and Ube3a-maternal-deficient mice to the presentation of novel object. The preference for the novel object was significantly lower in Ube3a-maternal-deficient mice in comparison with wild-type and Ube3a-paternal-deficient animals (Fig. 5B) . In light/dark box experiment, Ube3a-maternal-deficient mice spent significantly more time in the dark compartment than the wild-type and paternal-deficient mice (Fig. 5C) . Analysis of open-field behavior in a novel environment also revealed that Ube3a-maternal-deficient mice spent significantly more time and traveled more distance in the outer zone, and less frequently entered into the central area than the wild-type or paternal-deficient mice (Fig. 6 ). These mice also showed increased frequency of freezing. However, there was no significant difference in the total distance traveled by wild-type and mutant mice. The decrease in exploratory activity and the high freezing behavior in the open-field test is an indication of anxiety-like behavior.
Ube3a-maternal-deficient mice have reduced number of parvalbumin (PV)-positive GABAergic interneurons in their hippocampus
Defective GABAergic innervations have been observed in the hippocampus and amygdala of many mutant mice (thyroid hormone receptor, urokinase plasminogen activator receptor and Fmr1 knockout mice) that exhibit anxiety-like behavior (31) (32) (33) . Chronic stress is also reported to decrease the parvalbumin (PV)-positive GABAergic interneurons in the hippocampus (34) . We therefore explored similar alterations in inhibitory internuronal circuits in the hippocampus of Ube3a mutant mice. PV is a calcium-binding protein that detects a subpopulation of GABAergic interneurons (chandelier and basket cells) in the hippocampus, xand these inhibitory interneurons are implicated in the perisomatic control of pyramidal cells (35) . Figure S3 . Quantitative analysis revealed a significant reduction in the number of PV-immunoreactive inhibitory interneurons in most areas of hippocampus of Ube3a-maternal-deficient mice in comparison with wild-type mice (Fig. 7B) . The numbers of PV-positive interneurons in Ube3a-paternal-deficient mice were almost same as the wild-type mice (Supplementary Material, Fig. S3 ). We also observed imprinted expression of Expression of Ube3a, GR and SGK in amygdala in Ube3a-maternal-deficient mice Chronic stress or increased glucocorticoid level for prolonged periods is known to activate certain areas of amygdala and produce anxiety-like behavior (27) . Therefore, we further checked GR signaling in amygdala of Ube3a-maternal-deficient mice. Figure 8 shows that the expression of Ube3a was imprinted in the amygdala of Ube3a-maternal-deficient mice. The expression of GR in amygdala was unaltered in these mice, although the SGK1 level was reduced significantly. The decrease in the expression of SGK1 could be because of defective GR signaling in the absence of coactivator Ube3a.
DISCUSSION
In this study, we demonstrate that Ube3a acts as a transcriptional coactivator for GR and that GR signaling is impaired in the brain of Ube3a-maternal-deficient mice. Altered GR signaling in hippocampus might result in HPA axis hyperactivity, ultimately leading to chronic stress and increased anxiety in these mice. Ube3a has been shown to function as transcriptional coactivator of progesterone, estrogen and androgen receptors, and Ube3a null mice exhibit defects in reproductive function and tissue-specific steroid hormone resistance, indicating the prominent role of co-activator function of Ube3a in steroid hormone signaling pathways (13, 22, 23) . We find that Ube3a not only transactivates GR but also targets liganded GR for proteasomal degradation. Our findings suggest that both coactivator and ubiquitin ligase functions of Ube3a are coupled to each other in the dynamic regulation of glucocorticoid hormone signaling. Proteasome-mediated degradation of liganded steroid receptor is known to play a key role in regulating their transcriptional activity (36, 37) and Ube3a could play an important role in this process.
Interestingly, GR-mediated signaling pathway is deregulated in Ube3a-maternal-deficient mouse brain as evident from the decreased expression of GR-responsive genes, such as SGK1, BDNF and FKBP5. Most dramatic effect is observed in the hippocampus, which also showed a very significant reduction in GR expression without gross structural changes. Hippocampus of Ube3a-maternal-deficient mouse also exhibits reduced number of PV-positive GABAergic interneurons. The defective GR signaling along with decreased PV-positive GABAergic neurons in hippocampus could result in persistent activation of the HPA axis and increase in the secretion of glucocorticoids from the adrenal cortex by eliminating feedback inhibition (24) (25) (26) 34) . In fact, we have detected a significantly higher level of serum corticosterone in Ube3a-maternal-deficient mice. The hippocampus provides negative feedback control to the HPA axis that regulates physiologic response to stress by down-regulating corticotropin-releasing hormone (CRH) production in paraventricular nucleus (PVN) of hypothalamus (26, 28, 34, 38, 39) . The loss of hippocampal-negative feedback regulation of the HPA axis in Ube3a-maternal-deficient mice probably makes them more vulnerable to stress or chronically stressed that can further induce hippocampal changes. The reduced number of PV-positive inhibitory interneurons observed in the hippocampus of Ube3a-maternal-deficient mice again suggests that these mice are under chronic stress because chronic stress is known to decrease the number of PV-positive GABAergic interneurons in the hippocampus (34, 40) . However, the reduced number of PV-positive interneurons observed in Ube3a-maternal-deficient mice also could be developmental in origin, which needs further investigation. A growing body of evidence suggests that chronic stress or prolonged exposure of glucocorticoids can compromise hippocampal function by producing dendritic retraction without cell death (24, 41, 42) . Therefore, defect in hippocampal long-term potentiation and reduced numbers of dendritic branches and spines observed in the adult Ube3a-maternal-deficient mice could be explained at least in part due to chronic stress. However, we do not know whether our observations are age-dependent or not. Most of our experiments were conducted in 4-month-old male mice.
It would be interesting to study the age-dependent changes in GR signaling and alteration in the number of PV-positive interneurons in these mutant mice. Ube3a-maternal-deficient mice have been reported to show deregulation of AMPA receptor expression at synapse (because of altered degradation of Arc that is involved in AMPA receptor endocytosis), deficits in experience-dependent cortical and neocortical plasticity that could lead to developmental delay in cognitive and motor functions (18) (19) (20) . The Ube3a-maternal-deficient mice also exhibit increased anxiety-like behavior, and again this could be due to chronic stress and decrease in PV-immunorective inhibitory interneurons in the hippocampus. Decreased GABAergic inhibition could result in hippocampal hyperactivity leading to increased anxiety (43) . Similar findings are reported in thyroid hormone receptor and urokinase plasminogen activator receptor knockout mice and both these mutant mice exhibit increased anxiety-like behavior along with decrease in PV-positive inhibitory interneurons (32, 33) . Chronic exposure to high physiological levels of corticosterone in mice is sufficient to produce anxiety-like behavior and also results in dendritic hypertrophy in basolateral amygdala (27, 44) . Amygdala also provides positive feedback regulation to the HPA axis (27) . We have noticed unaltered GR levels in the amygdala of Ube3a-maternal-deficient mice brain. This indicates amygdala in these mice is not only able to contribute positive feedback regulation to the HPA axis but also might be involved in producing anxiety-like behavior, and in both cases expression of CRH might be critical. In fact, high levels of expression of CRH in specific nuclei of amygdala and bed nucleus of the stria terminalis is strongly associated with increased anxietylike behavior (27, 45) . It will be interesting to study the expression of CRH in the PVN of hypothalamus, amygdala and bed nucleus of stria terminalis in Ube3a-maternal-deficient mice to get further insight into the chronic stress-induced anxiety.
A recent report demonstrates reduced exploratory activity in the social seeking behavioral test in Ube3a-maternal-deficient mice (46) . Another mouse model with a large maternal deletion from Ube3a to Gabrb3 also shows anxiety-related behavior in the light/dark test (47) . Both these studies support our observations. The anxiety-like behavioral features also have been documented in few AS patients during their adulthood (48, 49) . However, it is not clear whether the deficiency of Ube3a is associated with anxiety-like behavior, because majority of these patients show large deletion of 15q11 -q13. It is also important to note that anxiety is frequently observed in children and adolescents with autism spectrum disorders (45, 50) . Our findings along with others suggest careful investigation of these behavioral features in AS patients. In conclusion, our study provides evidence for the first time that deranged GR signaling in hippocampus could lead to chronic stress and increased anxiety-like behavior in Ube3a-maternal-deficient mice.
MATERIALS AND METHODS
Materials
MG132, dexamethasone, RU486 and mouse monoclonal anti-b-tubulin and all cell culture reagents were obtained Figure 8 . Representative immunofluorescence staining of Ube3a, GR and SGK1 in the amygdala region of both wild-type and mutant mice. Brain sections collected from 4-month-old male mice were used for staining. FITCconjugated secondary antibody was used to detect Ube3a, GR and SGK1. Nuclei were counterstained with DAPI. Scale bar represents 20 mm.
from Sigma. Lipofactaminew 2000, Charcoal-stripped fetal bovine serum and V5 antibody were purchased from Invitrogen. Genomic DNA isolation kit was procured from MDI (India) and polymerase chain reaction (PCR) kit was from BD Biosciences. Protein-G agarose beads, mouse monoclonal GFP antibody and protease inhibitor cocktail were purchased from Roche. Rabbit polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH), anti-GR, anti-Ube3a and anti-SGK1 were from Santa Cruz Biotechnology. Mouse specific E6-AP and GAPDH siRNA oligoneucleotides (a pool of three target-specific 20 -30 nucleotide siRNA) were purchased from Santa Cruz Biotechnology and luciferase assay kit was purchased from Roche. ABC kits, goat anti-rabbit IgG-Rhodamine, goat anti-mouse IgG-fluorescein isothiocyanate (FITC), AP-conjugated anti-mouse and anti-rabbit IgG were purchased from Vector Laboratories. The construction of full-length E6-AP in pcDNA vector has been described earlier (51) and the C833A mutant was obtained from Addgene. The GR, GRE-Luc plasmids were obtained from Dr P. Roy, IIT Roorkee and GR-GFP plasmid from Dr R. Tyagi, Jawaharlal Nehru University, New Delhi.
Animals
Heterozygous Ube3a mice were obtained from Jackson Laboratory (Jackson code: 129-Ube3atm1Alb/J) and maintained in the C57BL/6 background. Animals had access to pelleted diet and water ad libitum. All animal experiments were carried out as per the institutional guidelines for the use and care of animals and cleared by instuitional animal ethics committee. All efforts were made to minimize animal suffering and to reduce the number of animals used. The genotyping was carried out using PCR as described previously (14) . Different crosses of mice were used to get maternal or paternal-deficient mice as shown earlier (14) . Mice used in all the experiments were 4-month-old males. The wild-type, Ube3a-maternal-or paternal-deficient mice used in the behavioral studies and other experiments were obtained from four to five different litters. Brain samples were collected and different parts were carefully dissected out and stored at 2808C.
Cell culture, transfection and reporter gene assay
Neuro 2a cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated charcoalstripped fetal bovine serum and antibiotics penicillin/streptomycin. For routine experiments, the cells were plated into six-well tissue culture plate at sub confluent density. After 24 h of plating, cells were transfected with various plasmids using Lipofactaminew 2000 according to the manufacturer's instruction and cells were processed for luciferase reporter assay, co-immunoprecipitation and immunoblotting experiments. Luciferase activity was measured according to the manufacturer's instruction. Values were normalized against per mg protein and data expressed as fold activation with respect to control.
Co-immunoprecipitation and immunoblotting experiment
Neuro 2a cells were transiently transfected with GR-GFP plasmid for 24 h, cells were washed with cold phosphatebuffered saline (PBS), collected and pelleted by centrifugation and lysed on ice for 30 min with NP-40 lysis buffer (50 mM Tris; pH 8.0, 150 mM NaCl, 1% NP-40, complete protease inhibitor cocktail). The cell lysates were briefly sonicated, centrifuged for 10 min at 15000g at 48C and the supernatants were used for immunoprecipitation as described earlier (52) . Cortical area of the brain was homogenized in the same buffer and centrifuged as above to collect the soluble supernatant. For each immunoprecipitation experiment, 200 mg protein in 0.2 ml NP40 lysis buffer was incubated with 2.5 mg of primary antibody. The total cell lysate and brain lysate collected from different regions or the immunoprecipitated proteins were separated through sodium dodecyl sulfatepolyacrylamide gel electrophoresis and processed for immunoblotting as described elsewhere (53) . All primary antibodies were used at 1:1000 dilution for immunoblotting except V5, which was used at 1:5000 dilution.
Immunofluorescence and immunohistochemical techniques
Neuro 2a cells grown in chamber slides for 24 h were left untreated or treated with dexamethasone (100 nM). Cells were washed twice with PBS, fixed with 4% paraformaldehyde in PBS for 20 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min, washed extensively, and then blocked with 5% non-fat dried milk in tris-buffered saline and Tween-20 (TBST) for 1 h. The cells were then incubated with primary antibodies (GR and Ube3a) overnight at 48C. After several washings with TBST, cells were incubated with appropriate fluorescent-labeled secondary antibody (1:500 dilutions) for 1 h, washed several times and then mounted. Samples were observed using a fluorescence microscope (Apotome, Zeiss), and digital images were assembled using Adobe Photoshop. Both GR and Ube3a antibodies were used in 1:500 dilutions.
Mice were perfused with PBS containing 4% paraformaldehyde in PBS, brain samples were collected and processed for cryosectioning with 20 mM thickness. The sections were then subjected to immunohistochemical and immunofluorescence staining for Ube3a, SGK, GR and PV as described earlier (54) . Staining was carried out using ABC kit from Vector Laboratories.
Chromatin immunoprecipitation
Neuro 2a cells were maintained in DMEM with charcoalstripped FBS for 24 h, treated with 100 nM of dexamethasone for 1 h and then subjected to chromatin extraction, purification and immunoprecipitation according to the manufacturer's instructions (Cell Signaling). Briefly, cells were fixed with formaldehyde, lysed, chromatins were extracted and fragmented by enzymatic digestion. Chromatin prepared from wild-type mice brains using same kit. The chromatin (20 mg) was then subjected to immunoprecipitation using Ube3a and GR antibodies (2 mg each). After immunoprecipitation, protein-DNA cross-links were reversed, DNA was purified and then processed for PCR using primers specific for SGK1 promoter or negative control region of the SGK1 gene (intron/exon region). The SGK1 promoter-specific and negative control primer sets were as follows: SGK1 promoter forward, 5
′ -CTAACTCGCCACCTCCTCAC-3 ′ ; and SGK1 promoter reverse, 5 ′ -GGG GCGGAAATAAGTCTCTG-3 ′ ; SGK1 negative control forward, 5
′ -CCTCCTCATCCTCCCT TCTC-3 ′ , SGK1 negative control reverse, 5 ′ -TCAGGTCA AGTGGCTGAGTG-3 ′ . The PCR was performed for 34 cycles with 30 s of denaturing at 948C, annealing for 30 s at 628C and extension at 728C for 30 s, followed by one cycle for 5 min at 728C.
Animal experimentation
Open-field test. Open-field apparatus consisted of an open box of 70 × 70 × 45 cm dimension. Entire field was divided into three zones; central core zone (central circle), outer zone (region of the field about 4 cm from the walls of the box) and inner zone (remaining area of the field barring the central and the outer zones). Each mouse was placed in the center of the field and the behavior was recorded for a period of 10 min using a digital video camera mounted above the apparatus. Parameters for evaluating anxiety included time spent in outer zone, frequency of entry into the central core zone and frequency of freezing. Total distance traveled by each mouse in the field for 10 min was also monitored as a measure of locomotor activity. All the analysis was performed using the Anymaze video-tracking system (Stoelting).
Novel object recognition test. The novel object recognition test was carried out in an open-field box (45 × 45 × 20 cm). Before training, mice were individually habituated by allowing them to explore the open-field box for three sessions (5 min in each session) per day for three consecutive days. During training session, two similar looking novel objects were placed into the open-field 12 cm away from each other (symmetrically) and the animal was allowed to explore them for 5 min. The time spent to explore each object was recorded. The animals were returned to their home cages immediately after training. During the retention test (for short-term memory), the animals were placed back into the same open-field box again after 2 h, and allowed to explore freely for 5 min. Now, one of the familiar objects used during training was replaced by a novel object. All objects were balanced in term of physical complexity and were emotionally neutral. The open-field and objects were thoroughly cleaned with 70% alcohol after each session to avoid possible instinctive odorant cues. Preference index, a ratio of the amount of time spent exploring any one of the two items (training session) or the novel object (retention session) over the total time spent exploring both objects, was used to measure recognition memory.
Light/dark box test. The mouse was placed in a dark box for 2 min for acclimatization. At the end of this period, the door separating the dark box and open-field was opened. The amount of time each mouse took to emerge fully from the enclosed area into the open area was measured.
Corticosterone assay
Morning basal corticosterone levels (collected between 10 and 11 am) were measured in wild-type, Ube3a-maternal-and paternal-deficient mice that were left undisturbed overnight. Mice were killed by decapitation, trunk blood was collected, serum was separated and stored at 2808C. Serum corticosterone levels were measured using enzyme-linked immunoassay kit (Cayman).
Statistical analysis
Statistical analysis was performed using the SigmaStat software. Values were expressed as mean + SD. In animal behavioral experiments, inter-group comparisons were performed by using one-way ANOVA followed by Turkey Post hoc test. In all other experiments, two-tailed Student's t-test was used for inter-group comparison. P , 0.05 was considered statistically significant.
